Overview
Yefei Wang practices in Shanghai, China. Wang is rated as an Advanced expert by MediFind in the treatment of Marginal Zone Lymphoma (MZL). Their top areas of expertise are Marginal Zone Lymphoma (MZL), Lacrimal Gland Tumor, Neurofibromatosis Type 1 (NF1), and Optic Glioma.
Their clinical research consists of co-authoring 36 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 3 articles in the study of Marginal Zone Lymphoma (MZL).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Lacrimal Gland TumorWang isAdvanced. Learn about Lacrimal Gland Tumor.
- Marginal Zone Lymphoma (MZL)
- Experienced
- Adenoid Cystic CarcinomaWang isExperienced. Learn about Adenoid Cystic Carcinoma.
- B-Cell LymphomaWang isExperienced. Learn about B-Cell Lymphoma.
- Lymphoid HyperplasiaWang isExperienced. Learn about Lymphoid Hyperplasia.
- NeurofibromatosisWang isExperienced. Learn about Neurofibromatosis.
- Neurofibromatosis Type 1 (NF1)
- Non-Hodgkin LymphomaWang isExperienced. Learn about Non-Hodgkin Lymphoma.